Heterogeneity in Treatment Effects

D.R. Zucker, C.H. Schmid, M.W. McIntosh, R.B. D'Agostino, H.P. Selker, J. Lau, Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment Journal of Clinical Epidemiology. ,vol. 50, pp. 401- 410 ,(1997) , 10.1016/S0895-4356(96)00429-5

Stephen Senn, Individual response to treatment: is it a valid assumption? BMJ. ,vol. 329, pp. 966- 968 ,(2004) , 10.1136/BMJ.329.7472.966

RICHARD L. KRAVITZ, NAIHUA DUAN, EDMUND J. NIEDZINSKI, M. CAMERON HAY, SASKIA K. SUBRAMANIAN, THOMAS S. WEISNER, What Ever Happened to N‐of‐1 Trials? Insiders' Perspectives and a Look to the Future Milbank Quarterly. ,vol. 86, pp. 533- 555 ,(2008) , 10.1111/J.1468-0009.2008.00533.X

David M. Kent, Jason Nelson, Issa J. Dahabreh, Peter M. Rothwell, Douglas G. Altman, Rodney A. Hayward, Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials. International Journal of Epidemiology. ,vol. 45, pp. 2075- 2088 ,(2016) , 10.1093/IJE/DYW118

Frank Davidoff, Can Knowledge About Heterogeneity in Treatment Effects Help Us Choose Wisely Annals of Internal Medicine. ,vol. 166, pp. 141- 142 ,(2017) , 10.7326/M16-1721